Filing Details
- Accession Number:
- 0001127602-13-003561
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-02-01 16:38:07
- Reporting Period:
- 2013-01-31
- Filing Date:
- 2013-02-01
- Accepted Time:
- 2013-02-01 16:38:07
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1520262 | Alkermes Plc. | ALKS | Pharmaceutical Preparations (2834) | 981007018 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1236440 | E Floyd Bloom | Connaught House 1 Burlington Road Dublin 4 Ireland | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Disposition | 2013-01-31 | 9,028 | $23.16 | 0 | No | 4 | S | Indirect | Floyd E Bloom Charitable Remainder Trust |
Ordinary Shares | Disposition | 2013-01-31 | 21,066 | $23.18 | 0 | No | 4 | S | Indirect | Jody Corey-Bloom Charitable Remainder Trust |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | Floyd E Bloom Charitable Remainder Trust |
No | 4 | S | Indirect | Jody Corey-Bloom Charitable Remainder Trust |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Ordinary Shares | 110,281 | Direct |
Footnotes
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.00 to $23.20. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.0723 to $23.23. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.